相关实验视频
Updated: May 17, 2025

03:26
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
2.0K
在毒素A排毒剂注射期间,血压可能会严重升高
Heinrich Schulte-Baukloh1,2,3, Catarina Weiss4, Burkert Pieske5
1Department of Urology, Charité- University Hospital Berlin, Berlin, Germany. heinrich.schulte-baukloh@charite.de.
World journal of urology
|April 3, 2025
概括
毒素A排毒剂注射 (BoNT/A-DI) 可以导致血压大幅上升,特别是在高血压患者中. 在BoNT/A-DI期间监测血压,并咨询高危人群的内科.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 心脏病学 心脏病学
- 神经学 神经学
背景情况:
- 毒素A排毒剂注射 (BoNT/A-DI) 是一种治疗多发性硬化症 (MS) 或脊髓损伤患者的过活性膀 (OAB) 和神经性膀 (NDO) 的方法.
- 该程序通常在局部麻醉下进行,因此血压监测对于评估自主功能和心血管风险至关重要.
研究的目的:
- 调查BoNT/A-DI对接受手术的患者血压和心脏压力的影响.
- 为了确定在BoNT/A-DI期间血压显著升高的风险较高的患者子组.
主要方法:
- 在局部麻醉下,在BoNT/A-DI之前,期间和之后,对70名因MS而患有OAB或NDO的患者进行了对生命指标 (血压,心率,RPP) 的监测.
- 患者根据高血压史,注射类型 (初始 vs 重复) 和基线血压 (高风险组:前20%).
主要成果:
- 在所有患者中,缩血压显著增加,平均为9.8mmHg.
- 患有高血压的患者经历了更明显的缩血压升高 (19.4 mmHg),缩血压峰值达到232 mmHg,缩血压高达128 mmHg.
- 心脏压力 (RPP) 在高血压患者和高风险组显著增加,表明心脏工作量增加.
结论:
- 临床医生必须在BoNT/A-DI期间监测血压,因为有明显升高的风险,特别是在有过高血压病史的患者中.
- 干预前血压升高需要及时咨询内部医学,以减轻与BoNT/A-DI相关的心血管风险.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
632
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
632
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
371
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
371
Depolarizing Blockers: Pharmocokinetics
297
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
297
Skeletal Muscle Relaxants: Adverse Effects
322
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
322
Disorders of the Autonomic Nervous System
492
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
492
Antihypertensive Drugs: Vasodilators
441
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
441

